Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KLAC vs MRNA✓SelectedUSD · MRNAKLAC vs MRNA performance historyLatest closeAs of-10.33%11/20
Stock and ETF performance explorer

KLAC vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,422.9%
MRNA return
+786.4%
Excess return
+636.5%
Maximum drawdown
-57.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-10.3%-2.2%-8.2%-10.2%
7D-16.6%-12.7%-3.9%-15.8%
30D-22.3%-20.7%-1.6%-21.1%
3M-31.6%+46.3%-77.9%-33.4%
6M-30.5%+305.2%-335.7%-41.9%
YTD+5.0%+561.2%-556.3%-18.0%
1Y+15.7%+772.1%-756.4%-12.8%
3Y+132.7%+147.0%-14.3%+95.8%
5Y+215.0%-26.1%+241.1%+185.1%
All+1,422.9%+786.4%+636.5%+1,171.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling